Article
Anaheim, CA-The Early Manifest Glaucoma Trial (EMGT) has provided the first estimate of treatment effectiveness in patients with early open-angle glaucoma. M. Cristina Leske, MD, MPH, described the findings of the trial and how they relate to clinical practice here at the American Academy of Ophthalmology annual meeting.